PDGFRB and Hypertension: Activation of PDGFR‐β was sufficient to drive progressive renal fibrosis, and this created a unique model allowing to specifically study the consequences, reversibility, and therapeutic interventions of renal fibrosis independent of inflammation, hypertension, or epithelial or endothelial injury.